Production (Stage)
Sarepta Therapeutics, Inc.
SRPT
$37.60
-$1.01-2.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -62.41% | -19.18% | -30.87% | -21.51% | -26.11% |
| Total Receivables | 72.76% | 48.69% | 45.65% | 46.83% | 45.58% |
| Inventory | 152.04% | 132.29% | 131.93% | 114.12% | 84.30% |
| Prepaid Expenses | -14.60% | 10.94% | 11.69% | 24.96% | 19.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -13.12% | 149.40% | 311.40% | 243.63% | 184.45% |
| Total Current Assets | -1.31% | 19.16% | 9.57% | 8.53% | -0.94% |
|
|
|||||
| Total Current Assets | -1.31% | 19.16% | 9.57% | 8.53% | -0.94% |
| Net Property, Plant & Equipment | 35.17% | 36.84% | 29.17% | 23.67% | 53.37% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.44% | -9.23% | 41.38% | 56.80% | 301.86% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.91% | -18.73% | -11.26% | 8.52% | 8.78% |
| Total Assets | 7.47% | 21.40% | 15.76% | 9.55% | 5.38% |
|
|
|||||
| Total Accounts Payable | 70.54% | 30.03% | 35.05% | -2.17% | -14.22% |
| Total Accrued Expenses | 14.44% | 22.10% | 6.90% | -6.01% | -38.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -89.35% | -87.42% | 506.56% | 539.32% | 601.09% |
| Total Finance Division Other Current Liabilities | 7.80% | 41.53% | 79.45% | 74.73% | 49.93% |
| Total Other Current Liabilities | 7.80% | 41.53% | 79.45% | 74.73% | 49.93% |
| Total Current Liabilities | -0.51% | 11.94% | 55.19% | 38.07% | 13.38% |
|
|
|||||
| Total Current Liabilities | -0.51% | 11.94% | 55.19% | 38.07% | 13.38% |
| Long-Term Debt | 0.41% | 0.41% | -8.15% | -8.15% | -8.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 46.65% | 36.54% | 26.16% | 11.17% | 159.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.94% | -21.74% | -28.62% | -27.03% | -27.06% |
| Total Liabilities | 2.63% | 1.26% | 1.43% | -1.56% | -3.57% |
|
|
|||||
| Common Stock & APIC | 7.99% | 8.19% | 6.32% | 5.55% | 4.51% |
| Retained Earnings | -5.63% | 5.29% | 2.71% | 1.06% | 0.38% |
| Treasury Stock & Other | 104.92% | -123.75% | 451.88% | 2.37% | -64.92% |
| Total Common Equity | 18.89% | 77.78% | 59.75% | 45.27% | 34.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.89% | 77.78% | 59.75% | 45.27% | 34.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.89% | 77.78% | 59.75% | 45.27% | 34.86% |
|
|
|||||